Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed News and Future Directions
Brain booster
Whodunit?
Low-Dose Naltrexone and Met-Enkephalin Improve EAE Mice
Gene Polymorphism Associated With Slower Evoked Potential Latency
Early-Detection Probe for MS Exploits Coagulation Protein
A Complementary Approach to Treating MS?
Genetic Marker May Underlie Sex Difference in MS Susceptibility
Survey Finds “MSer” to Be Patients' Preferred Descriptor
Stem Cells Enhanced to Generate Myelin-Producing Cells
Immunophenotyping Separates MS Subtypes by Neuroinflammation
Kir4.1 Potassium Channels in MS: Discrepant Results From Two Studies
A Better Interferon?
Cognitive Reserve in MS: Life Experiences Matter
Salt Sampler
Video Game Revs Up Brain Power
EDSS Alternative in an iPad
New MS Drug Candidate From Zebrafish Screen Targets IGF-1R Pathway
MS Research Roundup: July 9, 2014
MS Research Roundup: March 21, 2014
Abnormal Venous Outflow Dynamics May Not Be Implicated in MS
Epigenetic Changes Color the Genomes of People With MS
MS Patient, Ph.D.: Axes of Access Don’t Intersect for the Disabled Patient
Exploiting the EBV-MS Link to Quell Secondary Progressive Disease
First-Attack Multiple Sclerosis Targets Gray Matter
MS Gene Tests Inch Toward the Clinic
Pages
« first
‹ previous
…
4
5
6
7
8
9
10
11
12
…
next ›
last »